Literature DB >> 7720772

CNS research in the pharmaceutical industry. A personal view of how innovation could be promoted by clinical pharmacology.

R Horowski.   

Abstract

Mesh：

Substances：

Year:  1995        PMID： 7720772     DOI： 10.1007/bf00196864

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  5 in total

1.  Severe anxiety induced by FG 7142, a beta-carboline ligand for benzodiazepine receptors.

Authors:  R Dorow; R Horowski; G Paschelke; M Amin
Journal:  Lancet       Date:  1983-07-09       Impact factor: 79.321

2.  Cardiovascular research in the pharmaceutical industry: a personal appeal for rationalizing development.

Authors:  J Conway
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

Review 3.  Where have we got to with neuroreceptor mapping of the human brain?

Authors:  B Mazière; M Mazière
Journal:  Eur J Nucl Med       Date:  1990

4.  The role of D-1 and D-2 receptors.

Authors:  M Schachter; P Bédard; A G Debono; P Jenner; C D Marsden; P Price; J D Parkes; J Keenan; B Smith; J Rosenthaler; R Horowski; R Dorow
Journal:  Nature       Date:  1980-07-10       Impact factor: 49.962

5.  Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial. UBC MS/MRI Study Group and the IFNB Multiple Sclerosis Study Group.

Authors:  D W Paty; D K Li
Journal:  Neurology       Date:  1993-04       Impact factor: 9.910
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.